Avastin 400 mg (bevacizumab 400 mg) is a tumor-starving (anti-angiogenic) therapy. Avastin 400 mg (bevacizumab 400 mg) is designed to block a protein called vascular endothelial growth factor, or VEGF. Normal cells make VEGF, but some cancer cells make too much VEGF. Blocking VEGF may prevent the growth of new blood vessels, including normal blood vessels and blood vessels that feed tumors.
EKOM Pharmex, is amongst the leading Exporter and Dealers of this highly commendable and diverse range of Pharmaceutical Medicine.
***We Promise, no spam!